Viсtor Ryzhenko

Dr. Viсtor Ryzhenko

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
OPOlena Popazova
Olena Popazova
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
Sergii PavlovSergii Pavlov
Sergii Pavlov
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
The study of mitochondrial dysfunction has become increasingly pivotal in elucidating the pathophysiology of various cerebral pathologies, particularly neurodegenerative disorders. Mitochondria are essential for cellular energy metabolism, regulation of reactive oxygen species (ROS), calcium homeostasis, and the execution of apoptotic processes. Disruptions in mitochondrial function, driven by factors such as oxidative stress, excitotoxicity, and altered ion balance, lead to neuronal death and contribute to cognitive impairments in several brain diseases. Mitochondrial dysfunction can arise from genetic mutations, ischemic events, hypoxia, and other environmental factors. This article highlights the critical role of mitochondrial dysfunction in the progression of neurodegenerative diseases and discusses the need for targeted therapeutic strategies to attenuate cellular damage, restore mitochondrial function, and enhance neuroprotection.

21 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
OPOlena Popazova
Olena Popazova
IBIgor Belenichev
Igor Belenichev
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
Valentyn OksenychValentyn Oksenych
Valentyn Oksenych
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
Intrauterine hypoxia in newborns leads to a multifaceted array of alterations that exert a detrimental impact on the cardiovascular system. The aim of this research was to assess the cardioprotective effects of modulators of the nitric oxide (NO) system, including L-arginine, Thiotriazoline, Angiolin, and Mildronate, during the early postnatal period following intrauterine hypoxia. Methods: The study involved 50 female white rats. Pregnant female rats were given a daily intraperitoneal dose of 50 mg/kg of sodium nitrite starting on the 16th day of pregnancy. A control group of pregnant rats received saline instead. The resulting offspring were divided into the following groups: Group 1—intact rats; Group 2—rat pups subjected to prenatal hypoxia (PH) and daily treated with physiological saline; and Groups 3 to 6—rat pups exposed to prenatal hypoxia and treated daily from the 1st to the 30th day after birth. Nitrotyrosine levels, eNOS, iNOS, and NO metabolites were evaluated using ELISA; to measure the expression levels of iNOS mRNA and eNOS mRNA, a PCR test was utilized. Results: Angiolin enhances the expression of eNOS mRNA and boosts eNOS activity in the myocardium of rats with ischemic conditions. Arginine and particularly Thiotriazoline exhibited a consistent impact in restoring normal parameters of the cardiac nitroxidergic system following PH. Mildronate notably raised iNOS mRNA levels and notably reduced nitrotyrosine levels, providing further support for its antioxidative characteristics.

Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
LMLyudmyla Makyeyeva
Lyudmyla Makyeyeva
OMOksana Morozova
Oksana Morozova
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
The authors propose a novel approach to a comprehensive evaluation of neuroprotective effects using both in vitro and in vivo methods. This approach allows for the initial screening of numerous newly synthesized chemical compounds and substances from plant and animal sources while saving animal life by reducing the number of animals used in research. In vitro techniques, including mitochondrial suspensions and neuronal cell cultures, enable the assessment of neuroprotective activity, which can be challenging in intact organisms. The preliminary methods help outline the neuroprotection mechanism depending on the neurodestruction agent. The authors have validated a model of acute cerebrovascular accident, which simulates key cerebrovascular phenomena such as reduced cerebral blood flow, energy deficit, glutamate–calcium excitotoxicity, oxidative stress, and early gene expression. A significant advantage of this model is its ability to reproduce the clinical picture of cerebral ischemia: impaired motor activity; signs of neurological deficits (paresis, paralysis, etc.); as well as disturbances in attention, learning, and memory. Crucial to this approach is the selection of biochemical, molecular, and cellular markers to evaluate nerve tissue damage and characterize potential neuroprotective agents. Additionally, a comprehensive set of molecular, biochemical, histological, and immunohistochemical methods is proposed for evaluating neuroprotective effects and underlying mechanisms of potential pharmaceutical compounds.

16 January 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
OPOlena Popazova
Olena Popazova
OYOleh Yadlovskyi
Oleh Yadlovskyi
НБНина Бухтиярова
Нина Бухтиярова
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
Prenatal hypoxia (PH) is a key factor in the development of long-term cardiovascular disorders, which are caused by various mechanisms of endothelial dysfunction (ED), including those associated with NO deficiency. This emphasizes the potential of therapeutic agents with NO modulator properties, such as Thiotriazoline, Angiolin, Mildronate, and L-arginine, in the treatment of PH. Methods: Pregnant female rats were given a daily intraperitoneal dose of 50 mg/kg of sodium nitrite starting on the 16th day of pregnancy. A control group of pregnant rats received saline instead. The resulting offspring were divided into the following groups: Group 1—intact rats; Group 2—rat pups subjected to prenatal hypoxia (PH) and treated daily with physiological saline; and Groups 3 to 6—rat pups exposed to prenatal hypoxia and treated daily from the 1st to the 30th day after birth. Levels of sEPCR, Tie2 tyrosine kinase, VEGF-B, SOD1/Cu-Zn SOD, GPX4, and GPX1 in the heart’s cytosolic homogenate were assessed using ELISA. The expression of VEGF and VEGF-B mRNA was analyzed via real-time polymerase chain reaction, and the nuclear area of myocardial microvessel endothelial cells was evaluated morphometrically. Results: We have shown that only two representatives of this group—Angiolin and Thiotriazoline—are able to exert full effect on the indices of endothelial dysfunction after PH to decrease sEPCR, increase Tie-2, VEGF-B and VEGF-B mRNA, Cu/ZnSOD, and GPX in myocardial cytosol, and increase the area of endotheliocyte nuclei in 1- and 2-month-old rats in comparison with the control. Conclusions: Our results experimentally substantiate the necessity of early postnatal cardio- and endothelioprotection using NO modulators, taking into account the role of NO-dependent mechanisms in the pathogenesis of cardiovascular system disorders in neonates after PH.

3 July 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
IBIgor Belenichev
Igor Belenichev
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
OPOlena Popazova
Olena Popazova
НБНина Бухтиярова
Нина Бухтиярова
NGNadia Gorchakova
Nadia Gorchakova
Oleksandr KamyshnyiOleksandr Kamyshnyi
Oleksandr Kamyshnyi
For the first time, to optimize the creation of new neuroprotective agents based on bioflavonoids, we applied information technologies; these include docking analysis to calculate the binding of candidate molecules to the pharmacological target protein transthyretin as well as a program of virtual screening of NO scavengers. As a result of this approach, the substance catechin was isolated from candidate molecules—quercetin, catechin, Epicatechin gallate, Epicatechin, Procyanidin B1, Procyanidin B2, Procyanidin B3, and Catechin-3-gallate—according to docking analysis. As a result of virtual screening, catechin was identified as a potential NO scavenger (55.15% prediction). The results of the prediction were confirmed by in vitro experiments. Course administration of catechin to animals with experimental multiple sclerosis (MS) against the background of methylprednisolone administration completely eliminated lethal cases, reduced the number of diseased animals by 20% as well as prevented the development of severe neurological symptoms by 20% (compared to the methylprednisolone group) and by 60% compared to the control group. Course administration of catechin with methylprednisolone leads to a decrease in the neurodegradation markers in the cytosol of rats, with EAE: NSE by 37% and S-100 by 54.8%. The combined administration of methylprednisolone significantly exceeds the combination of methylprednisolone with the reference drug mexidol by the degree of NSE reduction. The obtained results indicate a significant neuroprotective effect of ocular combinations of methylprednisolone and catechin. The above-mentioned confirms the correctness of the bioflavonoid selection with the help of a virtual screening program.

7 December 2023 in Modern medical technology
Verified
Journal Article
Open access
PDF file
IBI. F. Bielenichev
I. F. Bielenichev
NGN. A. Gorchakova
N. A. Gorchakova
EDE. Yu. Doroshenko
E. Yu. Doroshenko
ISI. B. Samura
I. B. Samura
Viсtor RyzhenkoViсtor Ryzhenko
Viсtor Ryzhenko
NBN. V. Bukhtiiarova
N. V. Bukhtiiarova
Aim. The purpose of this study was to conduct an up-to-date semantic analysis of the results of our own research and literature data on the medical and pharmacological characteristics of metabolites, metabolitotropic agents and nutritional supplements, the peculiarities of their use in sports practice and sports medicine. Materials and methods. This study used bibliosemantic, analytical, logical, and generalization methods. The life sciences and biomedical information bibliographic databases MEDLINE, EMBASE, Medline (PubMed), Web of Science, and Cochrane Central were searched to find publications in English that matched the research keywords. The authors carried out an independent search and selection of articles, assessment of the quality of the data, compliance of the presentation and interpretation with the main idea of the study, with the formation of the final list of references. Results. Based on the analysis of modern literature data and the results of our own studies, a generalized medical and pharmacological characteristic of metabolite agents, metabolitotropic drugs and nutritional supplements that can influence the main and compensatory mechanisms of macroergic phosphates production under the influence of physical activity is presented. The mechanisms of action, indications for use and main side effects of drugs and food additives based on ATP, malate, succinate, citrate, pyruvate, carnitine, carnosine, etc. are presented. Conclusions. Semantic analysis data indicate that an urgent problem for sports medicine physicians and pharmacologists is the development and use of metabolites, metabolitotropic agents and nutritional supplements, as well as approaches to their rational combination to improve energy metabolism, replenish ATP reserves in the body that will help ensure the intensity muscular activity and simultaneously protect target organs. Мета роботи – надати актуальний семантичний аналіз результатів власних досліджень і відомостей фахової літератури щодо медико-фармакологічних характеристик метаболітних, метаболітотропних фармакологічних препаратів і харчових добавок, а також особливостей їх використання у спортивній медицині. Матеріали та методи. Під час дослідження використали бібліосемантичний, аналітичний, логічний методи, а також метод узагальнення. У бібліографічних базах даних наук про життя та біомедичної інформації MEDLINE, EMBASE, Medline (PubMed), Web of Science і Cochrane Central здійснили пошук англомовних публікацій, що відповідають ключовим словам дослідження. Здійснили самостійний пошук і відбір статей, оцінювання якості даних, відповідності викладу та інтерпретації основній ідеї дослідження, сформували остаточний список літератури. Результати. На основі аналізу відомостей сучасної фахової літератури, а також власних досліджень дали фармакологічну характеристику метаболітним, метаболітотропним препаратам і харчовим добавкам, що можуть впливати на основні механізми та компенсаторні шунти продукції макроергічних фосфатів під час тренувального процесу та фізичних навантажень. Наведено механізми дії, показання до застосування й основні побічні ефекти препаратів і харчових добавок на основі АТФ, малату, сукцинату, цитрату, пірувату, карнітину, карнозину тощо. Висновки. Зважаючи на результати семантичного аналізу, актуальним завданням для спортивного лікаря та фармаколога є розроблення метаболітотропних препаратів і харчових добавок, а також підходів до їх раціонального комбінування для покращення енергетичного обміну, поповнення запасів АТФ в організмі, що сприятиме забезпеченню інтенсивності м’язових скорочень та одночасному захисту органів-мішеней.